US Patent Issued to E&S HEALTHCARE on Feb. 3 for "Monoclonal antibody specifically binding to thioredoxin 1 and methods of use thereof for breast cancer diagnosis" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,942, issued on Feb. 3, was assigned to E&S HEALTHCARE Co. LTD. (Yuseong-Gu, South Korea).

"Monoclonal antibody specifically binding to thioredoxin 1 and methods of use thereof for breast cancer diagnosis" was invented by Kyong Hoon Suh (Daejeon, South Korea), Dae Joong Kim (Seoul, South Korea), Young Kim (Cheongju-si, South Korea), Mi Kyung Kim (Daejeon, South Korea), Jong Hwan Jung (Daejeon, South Korea) and Ki Se Lee (Sejong, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-b...